395 related articles for article (PubMed ID: 25467081)
1. Circulating microparticles in patients with antiphospholipid antibodies: characterization and associations.
Chaturvedi S; Cockrell E; Espinola R; Hsi L; Fulton S; Khan M; Li L; Fonseca F; Kundu S; McCrae KR
Thromb Res; 2015 Jan; 135(1):102-8. PubMed ID: 25467081
[TBL] [Abstract][Full Text] [Related]
2. Endothelial and platelet microparticles in patients with antiphospholipid antibodies.
Breen KA; Sanchez K; Kirkman N; Seed PT; Parmar K; Moore GW; Hunt BJ
Thromb Res; 2015 Feb; 135(2):368-74. PubMed ID: 25496997
[TBL] [Abstract][Full Text] [Related]
3. Platelet activation rather than endothelial injury identifies risk of thrombosis in subjects positive for antiphospholipid antibodies.
Jy W; Tiede M; Bidot CJ; Horstman LL; Jimenez JJ; Chirinos J; Ahn YS
Thromb Res; 2007; 121(3):319-25. PubMed ID: 17582471
[TBL] [Abstract][Full Text] [Related]
4. Altered β
Mobarrez F; Gunnarsson I; Svenungsson E
J Thromb Haemost; 2017 Sep; 15(9):1799-1806. PubMed ID: 28667788
[TBL] [Abstract][Full Text] [Related]
5. A new cytofluorimetric approach to evaluate the circulating microparticles in subjects with antiphospholipid antibodies.
Niccolai E; Squatrito D; Emmi G; Silvestri E; Emmi L; Ciucciarelli L; Ricci F; Manganaro D; Amedei A; Prisco D
Thromb Res; 2015 Dec; 136(6):1252-8. PubMed ID: 26476741
[TBL] [Abstract][Full Text] [Related]
6. Platelet and endothelial activation in catastrophic and quiescent antiphospholipid syndrome.
Bontadi A; Ruffatti A; Falcinelli E; Giannini S; Marturano A; Tonello M; Hoxha A; Pengo V; Punzi L; Momi S; Gresele P
Thromb Haemost; 2013 May; 109(5):901-8. PubMed ID: 23572134
[TBL] [Abstract][Full Text] [Related]
7. Anti-β2GPI antibodies stimulate endothelial cell microparticle release via a nonmuscle myosin II motor protein-dependent pathway.
Betapudi V; Lominadze G; Hsi L; Willard B; Wu M; McCrae KR
Blood; 2013 Nov; 122(23):3808-17. PubMed ID: 23954892
[TBL] [Abstract][Full Text] [Related]
8. Circulating cell-derived microparticles in severe preeclampsia and in fetal growth restriction.
Alijotas-Reig J; Palacio-Garcia C; Farran-Codina I; Ruiz-Romance M; Llurba E; Vilardell-Tarres M
Am J Reprod Immunol; 2012 Feb; 67(2):140-51. PubMed ID: 21992597
[TBL] [Abstract][Full Text] [Related]
9. Plasma microparticle tissue factor activity in patients with antiphospholipid antibodies with and without clinical complications.
Willemze R; Bradford RL; Mooberry MJ; Roubey RA; Key NS
Thromb Res; 2014 Feb; 133(2):187-9. PubMed ID: 24332063
[TBL] [Abstract][Full Text] [Related]
10. Circulating cell-derived microparticles in women with pregnancy loss.
Alijotas-Reig J; Palacio-Garcia C; Farran-Codina I; Zarzoso C; Cabero-Roura L; Vilardell-Tarres M
Am J Reprod Immunol; 2011 Sep; 66(3):199-208. PubMed ID: 21276118
[TBL] [Abstract][Full Text] [Related]
11. Small-size Microparticles as Indicators of Acute Decompensated State in Ischemic Heart Failure.
Montoro-García S; Shantsila E; Wrigley BJ; Tapp LD; Abellán Alemán J; Lip GY
Rev Esp Cardiol (Engl Ed); 2015 Nov; 68(11):951-8. PubMed ID: 25819989
[TBL] [Abstract][Full Text] [Related]
12. Persistency of low levels of anticardiolipin and anti-beta2 glycoprotein1 in thrombosis.
Amaral M; Favas C; Delgado Alves J
Eur J Intern Med; 2010 Apr; 21(2):101-3. PubMed ID: 20206880
[TBL] [Abstract][Full Text] [Related]
13. Detection of IgG anti-Domain I beta2 Glycoprotein I antibodies by chemiluminescence immunoassay in primary antiphospholipid syndrome.
Meneghel L; Ruffatti A; Gavasso S; Tonello M; Mattia E; Spiezia L; Tormene D; Hoxha A; Fedrigo M; Simioni P
Clin Chim Acta; 2015 Jun; 446():201-5. PubMed ID: 25935129
[TBL] [Abstract][Full Text] [Related]
14. Frequency of vascular and pregnancy morbidity in patients with low vs. moderate-to-high titers of antiphospholipid antibodies.
Ofer-Shiber S; Molad Y
Blood Coagul Fibrinolysis; 2015 Apr; 26(3):261-6. PubMed ID: 25526601
[TBL] [Abstract][Full Text] [Related]
15. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
16. Identification of thrombin antibodies in patients with antiphospholipid syndrome.
Miesbach W; Matthias T; Scharrer I
Ann N Y Acad Sci; 2005 Jun; 1050():250-6. PubMed ID: 16014540
[TBL] [Abstract][Full Text] [Related]
17. Circulating tissue factor positive microparticles in patients with acute recurrent deep venous thrombosis.
Ye R; Ye C; Huang Y; Liu L; Wang S
Thromb Res; 2012 Aug; 130(2):253-8. PubMed ID: 22099707
[TBL] [Abstract][Full Text] [Related]
18. Effect of anticardiolipin/beta2-glycoprotein I complexes on production of thromboxane A2 by platelets from patients with the antiphospholipid syndrome.
Robbins DL; Leung S; Miller-Blair DJ; Ziboh V
J Rheumatol; 1998 Jan; 25(1):51-6. PubMed ID: 9458202
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of anticardiolipin and anti-beta2-glycoprotein I antibodies.
Obermoser G; Bitterlich W; Kunz F; Sepp NT
Int Arch Allergy Immunol; 2004 Oct; 135(2):148-53. PubMed ID: 15345914
[TBL] [Abstract][Full Text] [Related]
20. Antibodies to beta2-glycoprotein-I: relation of anticardiolipin antibodies with clinical and laboratory parameters in patients with systemic lupus erythematosus.
Sahin M; Duzgun N; Tunc SE; Tutkak H
Clin Biochem; 2007 May; 40(8):526-30. PubMed ID: 17359958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
